Nicotinic ACh receptors as therapeutic targets in CNS disorders

Kelly Dineley, Anshul A. Pandya, Jerrel L. Yakel

Research output: Contribution to journalArticle

198 Citations (Scopus)

Abstract

The neurotransmitter acetylcholine (ACh) can regulate neuronal excitability by acting on the cys-loop cation-conducting ligand-gated nicotinic ACh receptor (nAChR) channels. These receptors are widely distributed throughout the central nervous system (CNS), being expressed on neurons and non-neuronal cells, where they participate in a variety of physiological responses such as anxiety, the central processing of pain, food intake, nicotine seeking behavior, and cognitive functions. In the mammalian brain, nine different subunits have been found thus far, which assemble into pentameric complexes with much subunit diversity; however, the α7 and α4β2 subtypes predominate in the CNS. Neuronal nAChR dysfunction is involved in the pathophysiology of many neurological disorders. Here we will briefly discuss the functional makeup and expression of the nAChRs in mammalian brain, and their role as targets in neurodegenerative diseases (in particular Alzheimer's disease, AD), neurodevelopmental disorders (in particular autism and schizophrenia), and neuropathic pain.

Original languageEnglish (US)
Pages (from-to)96-108
Number of pages13
JournalTrends in Pharmacological Sciences
Volume36
Issue number2
DOIs
StatePublished - 2015

Fingerprint

Central Nervous System Diseases
Nicotinic Receptors
Neurology
Brain
Central Nervous System
Neurodegenerative diseases
Neuralgia
Cholinergic Receptors
Autistic Disorder
Nervous System Diseases
Nicotine
Neurodegenerative Diseases
Cognition
Acetylcholine
Neurons
Neurotransmitter Agents
Cations
Schizophrenia
Alzheimer Disease
Anxiety

Keywords

  • cys-loop receptor
  • nAChR
  • α4β2 receptor
  • α7 receptor

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology

Cite this

Nicotinic ACh receptors as therapeutic targets in CNS disorders. / Dineley, Kelly; Pandya, Anshul A.; Yakel, Jerrel L.

In: Trends in Pharmacological Sciences, Vol. 36, No. 2, 2015, p. 96-108.

Research output: Contribution to journalArticle

Dineley, Kelly ; Pandya, Anshul A. ; Yakel, Jerrel L. / Nicotinic ACh receptors as therapeutic targets in CNS disorders. In: Trends in Pharmacological Sciences. 2015 ; Vol. 36, No. 2. pp. 96-108.
@article{695d46bf958e4a11998ba9c27286e025,
title = "Nicotinic ACh receptors as therapeutic targets in CNS disorders",
abstract = "The neurotransmitter acetylcholine (ACh) can regulate neuronal excitability by acting on the cys-loop cation-conducting ligand-gated nicotinic ACh receptor (nAChR) channels. These receptors are widely distributed throughout the central nervous system (CNS), being expressed on neurons and non-neuronal cells, where they participate in a variety of physiological responses such as anxiety, the central processing of pain, food intake, nicotine seeking behavior, and cognitive functions. In the mammalian brain, nine different subunits have been found thus far, which assemble into pentameric complexes with much subunit diversity; however, the α7 and α4β2 subtypes predominate in the CNS. Neuronal nAChR dysfunction is involved in the pathophysiology of many neurological disorders. Here we will briefly discuss the functional makeup and expression of the nAChRs in mammalian brain, and their role as targets in neurodegenerative diseases (in particular Alzheimer's disease, AD), neurodevelopmental disorders (in particular autism and schizophrenia), and neuropathic pain.",
keywords = "cys-loop receptor, nAChR, α4β2 receptor, α7 receptor",
author = "Kelly Dineley and Pandya, {Anshul A.} and Yakel, {Jerrel L.}",
year = "2015",
doi = "10.1016/j.tips.2014.12.002",
language = "English (US)",
volume = "36",
pages = "96--108",
journal = "Trends in Pharmacological Sciences",
issn = "0165-6147",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Nicotinic ACh receptors as therapeutic targets in CNS disorders

AU - Dineley, Kelly

AU - Pandya, Anshul A.

AU - Yakel, Jerrel L.

PY - 2015

Y1 - 2015

N2 - The neurotransmitter acetylcholine (ACh) can regulate neuronal excitability by acting on the cys-loop cation-conducting ligand-gated nicotinic ACh receptor (nAChR) channels. These receptors are widely distributed throughout the central nervous system (CNS), being expressed on neurons and non-neuronal cells, where they participate in a variety of physiological responses such as anxiety, the central processing of pain, food intake, nicotine seeking behavior, and cognitive functions. In the mammalian brain, nine different subunits have been found thus far, which assemble into pentameric complexes with much subunit diversity; however, the α7 and α4β2 subtypes predominate in the CNS. Neuronal nAChR dysfunction is involved in the pathophysiology of many neurological disorders. Here we will briefly discuss the functional makeup and expression of the nAChRs in mammalian brain, and their role as targets in neurodegenerative diseases (in particular Alzheimer's disease, AD), neurodevelopmental disorders (in particular autism and schizophrenia), and neuropathic pain.

AB - The neurotransmitter acetylcholine (ACh) can regulate neuronal excitability by acting on the cys-loop cation-conducting ligand-gated nicotinic ACh receptor (nAChR) channels. These receptors are widely distributed throughout the central nervous system (CNS), being expressed on neurons and non-neuronal cells, where they participate in a variety of physiological responses such as anxiety, the central processing of pain, food intake, nicotine seeking behavior, and cognitive functions. In the mammalian brain, nine different subunits have been found thus far, which assemble into pentameric complexes with much subunit diversity; however, the α7 and α4β2 subtypes predominate in the CNS. Neuronal nAChR dysfunction is involved in the pathophysiology of many neurological disorders. Here we will briefly discuss the functional makeup and expression of the nAChRs in mammalian brain, and their role as targets in neurodegenerative diseases (in particular Alzheimer's disease, AD), neurodevelopmental disorders (in particular autism and schizophrenia), and neuropathic pain.

KW - cys-loop receptor

KW - nAChR

KW - α4β2 receptor

KW - α7 receptor

UR - http://www.scopus.com/inward/record.url?scp=84922216722&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922216722&partnerID=8YFLogxK

U2 - 10.1016/j.tips.2014.12.002

DO - 10.1016/j.tips.2014.12.002

M3 - Article

C2 - 25639674

AN - SCOPUS:84922216722

VL - 36

SP - 96

EP - 108

JO - Trends in Pharmacological Sciences

JF - Trends in Pharmacological Sciences

SN - 0165-6147

IS - 2

ER -